Treatment of Anemia
The treatment of anemia should be tailored to its specific cause, with oral iron supplementation (ferrous sulfate 324 mg 2-3 times daily) being the first-line treatment for iron deficiency anemia, the most common form of anemia worldwide. 1
Diagnostic Approach to Guide Treatment
Before initiating treatment, it's essential to identify the underlying cause of anemia:
Iron deficiency anemia
- Laboratory findings: Low serum iron, low ferritin, low transferrin saturation, elevated total iron binding capacity
- Common causes: Blood loss, inadequate dietary intake, malabsorption
Vitamin deficiency anemia
- B12 deficiency: Macrocytic anemia, neurological symptoms
- Folate deficiency: Macrocytic anemia without neurological symptoms
Anemia of chronic disease/inflammation
- Laboratory findings: Low serum iron, normal/elevated ferritin, low transferrin
- Associated with chronic inflammation, autoimmune diseases, cancer, kidney failure 2
Other causes: Hemolytic anemia, aplastic anemia, thalassemia, sideroblastic anemia
Treatment Algorithms by Cause
1. Iron Deficiency Anemia
First-line: Oral iron supplementation
- Ferrous sulfate 324 mg (65 mg elemental iron) 2-3 times daily 1
- Continue therapy for 2-3 months after hemoglobin normalizes to replenish iron stores
- Take on empty stomach with vitamin C to enhance absorption
For poor response or intolerance to oral iron:
- Consider alternative iron formulations
- Parenteral iron if malabsorption is suspected 1
Address underlying cause:
- Investigate and treat source of blood loss
- Improve dietary iron intake
2. Vitamin B12 Deficiency
Pernicious anemia:
- Intramuscular vitamin B12 100 mcg daily for 6-7 days
- Then every other day for 7 doses
- Then every 3-4 days for 2-3 weeks
- Maintenance: 100 mcg monthly for life 3
Normal intestinal absorption:
- Initial treatment similar to pernicious anemia depending on severity
- Transition to oral B12 for chronic treatment 3
3. Folate Deficiency
- Oral folic acid supplementation
- Effective for megaloblastic anemias due to folate deficiency 4
- Particularly important in pregnancy, infancy, and childhood
4. Anemia of Chronic Disease/Inflammation
- Primary approach: Treat underlying condition
- Supplementation with iron, folic acid, and vitamin B12 as needed 2
- Consider erythropoiesis-stimulating agents (ESAs) in specific circumstances
- Important: ESAs should NOT be used in patients with mild to moderate anemia and heart failure or coronary heart disease 5, 1
5. Blood Transfusion Therapy
- Reserved for symptomatic anemia requiring immediate correction
- Use restrictive transfusion strategy (hemoglobin threshold of 7-8 g/dL) in most patients, including those with coronary heart disease 5, 1
- One unit of packed red blood cells typically increases hemoglobin by approximately 1 g/dL 1
Special Considerations
- Elderly patients: More susceptible to adverse effects of anemia; may require earlier intervention 6
- Cardiovascular disease: Use restrictive transfusion strategy (hemoglobin threshold of 7-8 g/dL) 5
- Pregnancy: Higher iron requirements; increased supplementation needed 1
Common Pitfalls to Avoid
- Failing to identify and treat the underlying cause of anemia
- Inappropriate iron supplementation in conditions where iron overload is a risk (e.g., thalassemia, sideroblastic anemia) 1
- Neglecting to continue iron therapy after hemoglobin normalizes (iron stores need replenishment)
- Using ESAs in patients with mild to moderate anemia and heart disease 5
- Transfusing more than the minimum number of RBC units necessary to relieve symptoms or reach safe hemoglobin levels 1